Summary: The procedures available for determination of clobazam (Frisium, Hoechst) are gas Chromatography, fluorometry, and thin-layer Chromatography. The study presents detailed descriptions of analytical procedures appropriate for routine determinations in serum and urine, and results from human trials. Moreover, the physicochemical properties of clobazam, viz., solubility, distribution, and protein binding are given.
Introduction
Methods are described for the determination of the new anxiolytic agent clobazam 1 ) (a 1,5-benzodiazepine (1)) in serum (gas Chromatography and fluorometry) and urine (thin-layer-chromatography). Clinically relevant physico-chemical data are also presented.
Clobazam

Reagents
Ethyl ether, ethyl acetate, both reagent grade; internal standard: 1 mg/1 diazepam in demineralized water.
Equipment
Glass stoppered centrifuge tubes volume about 10 ml: glass stoppered test tubes with tapered end after Beckett; Vortex mixer; refrigerating centrifuge; gas Chromatograph; integrator HP 3380.
Processing
To 1 ml serum in a centrifuge tube add 0.1 ml of the internal standard solution, and mix with 5 ml ethyl ether on a Vortex mixer for 30 s. Centrifuge for 5 min in a refrigerating centrifuge at 0-5°C, transfer about 4 ml of the organic phase to a Beckett tube, and evaporate to dryness at about 40 °C under nitrogen flow. Take up the residue with 50 \ ethyl acetate, and keep in a refrigerator until analysis.
Gaschromatographic Determination in Serum
Clobazam and its main metabolite in serum, N-desmethylclobazam, are determined by gas Chromatography using procedure akeady described for 1,4abenzpdiaẑ epines (2-4).
*) Frisium®, Hoechst Aktiengesellschaft.
Gas-chromatography Apparatus:
Column: Stationary phase:
Temperature:
Hewlett-Packard 5700 with nitrogen-specific FID 18 789 A and glass- Figure 1 shows the chromatograms of a serum blank, a serum blank with the addition of 0.05 mg/1 of clobazam and N-desmethylclobazam, and a patient's serum containing 0.2 mg/1 clobazam and 0.11 mg/1 N-desmethylclobazam. Evaluation was carried out with the integrator by an internal standard procedure, in which the peak areas of the compounds to be determined are compared with the peak area of diazepam.
Evaluation may also be performed by comparing the corresponding peak heights in the chromatogram. The linearity of this evaluation method was verified with mixtures of the pure compounds in ethyl acetate in the range 1 to 25 ng injected (r = 0.9992).
Precision and accuracy
Mixtures of clobazam and N-desmethylclobazam were diluted in serum. The serum samples were split in order to obtain six identical dilution series.
These series were analysed consecutively and gave the following results (tab. 1). Although the above-mentioned correlation is not satisfactory for N-desmethylclobazam, we prefer to describe the error dependency in the same way, resulting in 0.006 mg/1 + 2.5 % of the value measured.
The precision of the method thus obtained enables the limit of detection for quantitative determinations to be easily assessed. On the first day, the maximum serum level of clobazam (0.31 mg/1) was reached two hours after the administration. The elimination half-life was eight hours. N-desmethylclobazam was detected in the blood not earlier than eight hours after administration in a concentration of only 0.05 mg/1.
On the fourth day of treatment, the clobazam levels reached a steady state of 0.90 ± 0.23 mg/1. N-desmethylclobazam which had a half-life of 50 hours reached a steady state approximately on the 9th day of treatment at serum levels of 3.6 ± 1.3 mg/1. An example for the course of serum levels is shown iri figure 2.
Fluorometric Determination in Serum
Clobazam can also be determined by fluorometry. It does not show native fluorescence, but can be transforme d into a fluorophore by irradiation with shortwave UV light (6). The advantage of the method is that it is independent of a blank value as the sample is measured before and after irradiation. This transformation shows goodreproducibiliity (ef. I.e. (7)). 
Equipment
Glass stoppered centrifuge tubes, volume about 10 ml; Vortex mixer; centrifuge; Pen-Ray lamp 11 Sc 1 (UltraViolet Products, Inc., San Gabriel, California); irradiation chamber with two 1 cm cells; fluorometer Perkin Elmer MPF3.
Processing To 1 ml serum in a centrifuge tube add 5 ml ethyl ether, and shake for 30 s on a Vortex mixer. Centrifuge briefly, pipet off 4 ml from the supernatant ether phase into a test tube, and evaporate to dry ness at about 40 °C under nitrogen flow. Take up the residue with 2 ml ethyl alcohol (sample solution) and keep protected from light until fluorometric measurement.
Fluorometric measurement
In the irradiation chamber, irradiate 2 ml standard solution with UV light in a 1 cm cell for about one minute. The irradiation time depends on the intensity of the lamp and has to be readjusted from time to time. Adjust the scale reading obtained from the irradiated standard solution to 100% amplitude by means of the sample adjust button. This adjustment remains unchanged during sample measurement.
Fill the sample solution into a cell and measure (value 1). Subsequently, irradiate the sample solution for exactly the same time as the standard solution and measure again (value 2). Value 1 (non-irradiated solution) is regarded as blank value and subtracted from value 2 prior tp calculation. Calibration curves are established with sera containing standard quantities of the compound. Calibration is linear up to a concentration of 5 mg/1.
Precision and limit of detection
The data (tab. 2) show a constant precision of the method of 0.016 mg/1 within the concentration range 0.1 to 1.0 mg/1 serum. Consequently, the limit of detection (cf. paragraph oil gas chromatography) is 0.04 mg/1. Although the fluorometric method is less specific than gas chromatography, it is a useful alternative for singledose serum kinetics (cf. next paragraph), where these metabolites are only found in negligible serum concentrations (8). Stewart et al. showed (7) that the selectivity can be improved by using hexane as extraction agent.
Comparison of the methods
The quality of both methods is best demonstrated by parallel determinations in human trials. The results obtained from parallel determinations performed 0 to 24 hours after administration to 10 test persons correlate well (cf. fig.3 It should be mentioned that this correlation exclusively refers to clobazam, because N-desmethylclobazam was found only in negligible amounts.
Thin-layer Chromatographie determination in urine
Clobazam and the main metabolites in man, dog, and monkey -N-desmethylclobazam, 4'-hydroxyclobazam, and 4'-hydroxy-N-desmethylclobazam -can also be quantitatively determined by thin-layer chromatography. The compounds are easily separated on silica gel, using the mobile phase chloroform/n-heptane/methanol (85 ml + 10 ml + 5 ml). Quantitative evaluation is carried put by reflectance measurement with the usual TLC evaluating devices (densitometers) at 230 nm.
As a large amount of the metabolites is excreted as conjugates (8), the urine has to be treated with glucuronidase before determination. Processing a) Free compounds To 1 ml urine in a centrifuge tube add 1 ml phosphate buffer pH 7.5, and mix with 5 ml ethyl acetate on a Vortex mixer for 30 s. Centrifuge for 5 min at 4,000 rpm, transfer about 4.5 ml of the organic phase to a centrifuge tube, treat with 1 ml 0,01 mol/1 NaOH, and shake again on a Vortex mixer for 30 s. Centrifuge, discard the (lower) aqueous layer, and treat about 4.2 ml of the organic phase with 1 ml 0.01 mol/1 HC1 in the same way. Subsequently, evaporate 4 ml of the organic phase at about 40°C under nitrogen flow. Take up the residue with 100 ! methanol before application.
b) Conjugated compounds Treat 1 ml urine in a centrifuge tube with 1 ml acetate buffer pH 5.5 and 5 ml ethyl acetate on a Vortex mixer for 30 s in order to separate the free compounds. Extract again with 5 ml ethyl acetate. Treat the remaining aqueous phase 2 ) with 10 0-glucuronidase, and digest at 37°C in a water bath for 48 h. Subsequently add 1 ml phosphate buffer pH 7,5 and proceed as described under "Free compounds".
Application and development
The autospotter is able to apply up to 20 samples simultaneously onto a TLC plate, whereby optimal adjustment secures minimal spot size. Apply onto a plate 14 extracts of samples to be measured, 5 extracts of known admixtures, and a sample of pure substance. 
Evaluation
Evaluation on the basis of the peak areas is done by hand or by means of an integrator. For each plate, the calibration is calculated separately from admixtures to urine. Linearity is secured up to a concentration of 1 mg/1 urine. At higher concentrations, either less urine is used or a smaller aliquot is applied onto the plate.
Results from addition of standard substances to urine Since the original substance is not found in urine (6), only the metabolites were added. These dilutions were split into 21 identical samples arid processed as described for free and conjugated compounds. The following results were obtained (tab. 3).
Free compounds
Precision for all three metabolites is 0.025 mg/1 + 4% of value. The limit of detection calculated from this is 0.05 mg/1 (c. f. paragraph on gas chromatography). 
Conjugated compounds
Protein binding
Protein binding of the compound was determined by equilibrium dialysis according to Scholtan (9) . Solutions of 0.125-2.0 mg/1 clobazam in human serum were diälyzed against 0.067 mol/1 phosphate buffer pH 7 at room temperature overnight. At equilibrium clobazam was determined fluorometrically in serum and the corresponding buffer solutions. The adsorption isotherm after Freundlich (cf. fig. 6 ) gave the following equation:
log Cbound = 0.925 X log c free + 0.780 ± 0.045
i.e., 85 to 90 percent clobazam is bound to serum protein at therapeutical levels (0.1-1.6 mg/1). Similar results were obtained with ultracentrifugation (Centriflo membrane cones from Amieon, Lexington, Mass./USA). 
